Join
Live feed
·
PRReleasevia Quantisnow
enGene Therapeutics Inc. logo

enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones

ByQuantisnow·Wall Street's wire, on your screen.
ENGN· enGene Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENGN (enGene Therapeutics Inc.) and more on Quantisnow.